We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Researchers Produce Stable RNA Nanoparticles

By LabMedica International staff writers
Posted on 01 Feb 2011
The emerging field of RNA nanotechnology received a boost from the recently reported development of RNase- resistant RNA nanoparticles.

Use of RNA as the basis for nanoparticle manufacture has lagged behind the use of DNA largely due to the greater susceptibility of RNA to enzymatic degradation (principally by RNase). More...
However, investigators at the University of Cincinnati (OH, USA) have found a solution to this problem.

They reported in the December 14, 2010, online edition of the journal ACS Nano that chemically modified 2′-F (2′-fluoro) RNA was resistant to RNase digestion. The 2′-F RNA could be incorporated into nanoparticles that retained the RNA's property for correct folding in dimer formation, appropriate structure in pro-capsid binding, and its biological activity in packaging viral DNA and producing infectious viral particles.

The authors concluded that, "They had demonstrated that it is practical to produce RNase-resistant, biologically active, and stable RNA for application in nanotechnology.”

Related Links:

University of Cincinnati




New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Clinical Informatics Platform
CLARION™
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.